ロード中...
Guidelines for the use and management of long-acting injectable antipsychotics in serious mental illness
BACKGROUND: Long-acting injectable (LAI) formulations are not widely used in routine practice even though they offer advantages in terms of relapse prevention. As part of a process to improve the quality of care, the French Association for Biological Psychiatry and Neuropsychopharmacology (AFPBN) el...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3898013/ https://ncbi.nlm.nih.gov/pubmed/24359031 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-244X-13-340 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|